Cidara Therapeutics, Inc.CDTXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -223.65% |
| Q2 2025 | -8.37% |
| Q1 2025 | 53.36% |
| Q4 2024 | -211.50% |
| Q3 2024 | 81.88% |
| Q2 2024 | -1023.67% |
| Q1 2024 | -40.63% |
| Q4 2023 | -35.94% |
| Q3 2023 | 33.79% |
| Q2 2023 | -342.65% |
| Q1 2023 | 120.96% |
| Q4 2022 | -188.90% |
| Q3 2022 | 213.80% |
| Q2 2022 | 28.19% |
| Q1 2022 | -8.89% |
| Q4 2021 | 7.02% |
| Q3 2021 | -267.42% |
| Q2 2021 | 159.12% |
| Q1 2021 | 15.44% |
| Q4 2020 | -22.93% |
| Q3 2020 | 3.74% |
| Q2 2020 | -25.07% |
| Q1 2020 | -3.42% |
| Q4 2019 | -564.99% |
| Q3 2019 | 121.22% |
| Q2 2019 | 13.02% |
| Q1 2019 | 1.17% |
| Q4 2018 | -12.72% |
| Q3 2018 | 2.82% |
| Q2 2018 | 9.86% |
| Q1 2018 | -24.90% |
| Q4 2017 | -9.88% |
| Q3 2017 | 26.28% |
| Q2 2017 | -24.01% |
| Q1 2017 | 6.65% |
| Q4 2016 | -16.35% |
| Q3 2016 | -4.00% |
| Q2 2016 | -20.00% |
| Q1 2016 | 0.43% |
| Q4 2015 | -7.83% |